Rise Advisors »

Sunshine Biopharma shares owned by Rise Advisors

Quarter-by-quarter ownership of Sunshine Biopharma shares owned by Rise Advisors from 13F filings

Historical chart of Rise Advisors investment in Sunshine Biopharma

Tip: Access up to 7 years of quarterly data

All positions including Sunshine Biopharma held by Rise Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Sunshine Biopharma by Rise Advisors

Quarter filed Position value Share count Share price at filing
2024-09-30 $3 1 3.00

More positions owned by Rise Advisors

Vanguard Value Etf 0 (VTV)
Vanguard Growth Etf 0 (VUG)
Dimensional Core Fixed Income Etf 0 (DFCF)
Janus Henderson Mortgage-backed Securities Etf 0 (JMBS)
Janus Henderson Short Duration Income Etf 0 (VNLA)
Dimensional U.s. Targeted Value Etf 0 (DFAT)
Financial Select Sector Spdr Fund 0 (XLF)
Industrial Select Sector Spdr Fund 0 (XLI)
Wisdomtree Emerging Markets Ex-state-owned Enterprises Fund 0 (XSOE)
Paypal Hldgs 0 (PYPL)
Nvidia Corporation 0 (NVDA)
Microsoft Corp 0 (MSFT)
Berkshire Hathaway Inc Del Cl B 0 (BRK.B)
Amazon 0 (AMZN)
Alphabet Inc Cap Stk Cl C 0 (GOOG)

View all positions for Rise Advisors

Top funds holding Sunshine Biopharma

Bank of America Corporation
Nordwand Advisors
National Bank Of Canada /fi/
Jaffetilchin Investment Partners
Advisor Group Holdings
Rise Advisors
Farther Finance Advisors
TD Waterhouse Canada
Federation des caisses Desjardins du Quebec

View all funds holding Sunshine Biopharma